Tang Rui, Luo Jing, Zhu Xiaoxia, Miao Pengyu, Tang Hong, Jian Yue, Ruan Sibei, Ling Feng, Tang Mingxi
School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan, China.
Department of Pathology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
Front Mol Biosci. 2023 Sep 26;10:1258870. doi: 10.3389/fmolb.2023.1258870. eCollection 2023.
Fibrosis is a common pathological process that must take place for multiple chronic liver diseases to develop into cirrhosis and liver cancer. Liver fibrosis (LF) is regulated by various cytokines and signaling pathways in its occurrence and development. Ferroptosis is an important mode of cell death caused by iron-dependent oxidative damage and is regulated by iron metabolism and lipid peroxidation signaling pathways. In recent years, numerous studies have shown that ferroptosis is closely related to LF. As the main material secreted by the extracellular matrix, hepatic stellate cells (HSCs) are a general concern in the development of LF. Therefore, targeting HSC ferroptosis against LF is crucial. This review describes the current status of treating LF by inducing HSC ferroptosis that would aid studies in better understanding the current knowledge on ferroptosis in HSCs and the future research direction in this field.
纤维化是一种常见的病理过程,多种慢性肝病发展为肝硬化和肝癌都必经此过程。肝纤维化(LF)在其发生发展过程中受多种细胞因子和信号通路调控。铁死亡是由铁依赖性氧化损伤引起的一种重要细胞死亡方式,受铁代谢和脂质过氧化信号通路调控。近年来,大量研究表明铁死亡与肝纤维化密切相关。肝星状细胞(HSCs)作为细胞外基质分泌的主要物质,是肝纤维化发展过程中的一个普遍关注点。因此,针对肝星状细胞铁死亡治疗肝纤维化至关重要。本文综述了通过诱导肝星状细胞铁死亡治疗肝纤维化的现状,这将有助于更好地理解当前关于肝星状细胞铁死亡的知识以及该领域未来的研究方向。